Zobrazeno 1 - 10
of 8 369
pro vyhledávání: '"Donald A. Miller"'
Publikováno v:
In Journal of Voice May 2023 37(3):305-313
Autor:
Rawlinson, John
Publikováno v:
Anglican and Episcopal History, 2022 Dec 01. 91(4), 516-517.
Externí odkaz:
https://www.jstor.org/stable/27176146
Publikováno v:
JAAD International, Vol 16, Iss , Pp 26-28 (2024)
Externí odkaz:
https://doaj.org/article/e4ad9b7579bc46f6bbb6f70609483c93
Autor:
Dorrien, Gary
Publikováno v:
Journal of the American Academy of Religion, 1999 Dec 01. 67(4), 905-908.
Externí odkaz:
https://www.jstor.org/stable/1466288
Publikováno v:
Frontiers in Ecology and Evolution, Vol 12 (2024)
Externí odkaz:
https://doaj.org/article/95b02ba1e6d3407f926ad7a0ed6c3854
Autor:
Beyer, Peter
Publikováno v:
Sociology of Religion, 2015 Apr 01. 76(1), 125-126.
Externí odkaz:
http://www.jstor.org/stable/24580167
Autor:
Alfaro, Sammy
Publikováno v:
Journal of the American Academy of Religion, 2014 Dec 01. 82(4), 1166-1169.
Externí odkaz:
https://www.jstor.org/stable/44945122
Autor:
BOWLER, KATE
Publikováno v:
Journal for the Scientific Study of Religion, 2014 Dec 01. 53(4), 852-853.
Externí odkaz:
http://www.jstor.org/stable/24644311
Autor:
Samantha Walczuk, Francesca E. Cunningham, Xinhua Zhao, Diane Dong, Peter A. Glassman, Donald R. Miller, Deborah Khachikian, Anthony Au, Cedric Salone, Kelly Bryan, Qoua Her, Sherrie L. Aspinall
Publikováno v:
Pharmacoepidemiology, Vol 3, Iss 1, Pp 103-116 (2024)
We described insulin glargine (originator) and insulin glargine-yfgn (biosimilar) treatment patterns, assessed effectiveness and safety outcomes, and identified reasons for switching back to the originator product from the biosimilar. This retrospect
Externí odkaz:
https://doaj.org/article/a298ba3cf45d4a1b980727b718f42035
Autor:
Akshitkumar M. Mistry, Jonah Daneshmand, SeonYeong Jamie Seo, Norman L. Lehman, Donald M. Miller, Dylan A. Goodin, Hermann B. Frieboes, Joseph Chen, Adrianna Masters, Brian J. Williams, Kavitha Yaddanapudi
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1183-1194 (2024)
Background: Glioblastoma (GBM) tumors are rich in tumor-associated microglia/macrophages. Changes associated with treatment in this specific cell population are poorly understood. Therefore, we studied changes in gene expression of tumor-associated m
Externí odkaz:
https://doaj.org/article/85788d9952204c5aad467501a1f17cd6